The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases

Archives of Dermatological Research

Volumn 299, Issue 1, 2007, Pages 1-8

  Sitaru, Cassian ^a   Mihai, Sidonia ^a   Zillikens, Detlef ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Autoimmune bullous diseases; Complement; IgG subclasses

Indexed keywords

AUTOANTIBODY; COLLAGEN TYPE 7; COLLAGEN TYPE 7 ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACANTHOLYSIS; ANTIBODY DETECTION; ANTIBODY RESPONSE; AUTOIMMUNE DISEASE; BLISTER; BULLOUS PEMPHIGOID; BULLOUS SKIN DISEASE; CELL ADHESION; COMPLEMENT ACTIVATION; ENTERITIS; EXTRACELLULAR MATRIX; HUMAN; IMMUNOPATHOGENESIS; LEUKOCYTE ACTIVATION; MUCOUS MEMBRANE PEMPHIGOID; NONHUMAN; PEMPHIGOID GESTATIONIS; PEMPHIGUS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BLISTER; HUMANS; IMMUNOGLOBULIN G; KERATINOCYTES; PEMPHIGUS; SKIN DISEASES, VESICULOBULLOUS;

EID: 34248150428     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-007-0734-0     Document Type: Review

References (88)

1. Al-Karawi KS (2002) Immunoglobulin G subclass distribution of bullous pemphigoid autoantibodies and complement Wxation studies. Saudi Med J 23:1492-1495
2. Allen EM, Giudice GJ, Diaz LA (1993) Subclass reactivity of pemphigus foliaceus autoantibodies with recombinant human desmoglein. J Invest Dermatol 100:685-691
3. Amagai M, Tsunoda K, Suzuki H, Nishifuji K, Koyasu S, Nishikawa T (2000) Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J Clin Invest 105:625-631
4. Anhalt GJ, Till GO, Diaz LA, Labib RS, Patel HP, Eaglstein NF (1986) Defining the role of complement in experimental pemphigus vulgaris in mice. J Immunol 137:2835-2840
5. Ayatollahi M, Joubeh S, Mortazavi H, Jefferis R, Ghaderi A (2004) IgG4 as the predominant autoantibody in sera from patients with active state of pemphigus vulgaris. J Eur Acad Dermatol Venereol 18:241-242
6. Bernard P, Aucouturier P, Denis F, Bonnetblanc JM (1990) Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid. Clin Immunol Immunopathol 54:484-494
7. Bernard P, Prost C, Aucouturier P, Durepaire N, Denis F, Bonnetblanc JM (1991) The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J Invest Dermatol 97:259-263
8. Bhol K, Mohimen A, Ahmed AR (1994) Correlation of subclasses of IgG with disease activity in pemphigus vulgaris. Dermatology 189:85-89
9. Bhol K, Natarajan K, Nagarwalla N, Mohimen A, Aoki V, Ahmed AR (1995) Correlation of peptide specificity and IgG subclass with pathogenic and non-pathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci USA 92:5239-5243
10. Bird P, Friedmann PS, Ling N, Bird AG, Thompson RA (1986) Subclass distribution of IgG autoantibodies in bullous pemphigoid. J Invest Dermatol 86:21-25
11. Brooks WS, Lee YY, Abell E, Deng JS (1989) Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus. J Clin Lab Anal 3:307-311
12. Buschman KE, Seraly M, Thong HY, Deng JS, Draviam RP, Abernethy JL (2002) A predominant IgG4 subclass may be responsible for false-negative direct immunofluorescence in bullous pemphigoid. J Cutan Pathol 29:282-286
13. Chen M, O'Toole EA, Sanghavi J, Mahmud N, Kelleher D, Weir D, Fairley JA, Woodley DT (2002) The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn's disease have autoantibodies to type VII collagen. J Invest Dermatol 118:1059-1064
14. Chimanovitch I, Schmidt E, Messer G, Dopp R, Partscht K, Bröcker EB, Giudice GJ, Zillikens D (1999) IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16A domain of BP180 in pemphigoid gestationis. J Invest Dermatol 113:140-142
15. Cho HJ, Lee IJ, Kim SC (1998) Complement-fixing abilities and IgG subclasses of autoantibodies in epidermolysis bullosa acquisita. Yonsei Med J 39:339-344
16. David M, Katzenelson V, Hazaz B, Ben-Chetrit A, Sandbank M (1989) Determination of IgG subclasses in patients with pemphigus with active disease and in remission. Arch Dermatol 125:787-790
17. David M, Katzenelson V, Mimouni D, Milner Y (2006) The distribution of pemphigus vulgaris-IgG subclasses in patients with active disease. J Eur Acad Dermatol Venereol 20:232
18. Dmochowski M, Hashimoto T, Nishikawa T (1992) The analysis of IgG subclasses of anti-intercellular antibodies in pemphigus by an immunoblot technique. Arch Dermatol Res 284:309-311
19. Döpp R, Schmidt E, Chimanovitch I, Leverkus M, Bröcker EB, Zillikens D (2000) IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol 42:577-583
20. Dray S (1960) Three gamma-globulins in normal human serum revealed by monkey precipitins. Science 132:1313-1314
21. Espana A, Diaz LA, Mascaro JM Jr, Giudice GJ, Fairley JA, Till GO, Liu Z (1997) Mechanisms of acantholysis in pemphigus foliaceus. Clin Immunol Immunopathol 85:83-89
22. Flotte TJ, Baird LG (1986) Immunoglobulin light and heavy chain isotypes in skin diseases: restricted distribution in bullous pemphigoid and linear IgA bullous dermatosis. J Immunol 136:491-496
23. Futei Y, Amagai M, Ishii K, Kuroda-Kinoshita K, Ohya K, Nishikawa T (2001) Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. J Dermatol Sci 26:55-61
24. Futei Y, Amagai M, Hashimoto T, Nishikawa T (2003) Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus. J Am Acad Dermatol 49:1023-1028
25. Gammon WR, Briggaman RA (1993) Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol Clin 11:535-547
26. Gandhi K, Chen M, Aasi S, Lapiere J-C, Woodley D, Chan LC (2000) Autoantibodies to type VII collagen have heterogenous subclass and light chain compositions and their complement-activating capacitities do not correlate with the inflammatory clinical phenotype. J Clin Immunol 20:416-423
27. Grey HM, Kunkel HG (1964) H-chain subgroups of myeloma proteins and normal 7s-gammaglobulins. J Exp Med 120:253-266
28. Hacker MK, Janson M, Fairley JA, Lin MS (2002) Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies. Clin Immunol 105:64-74
29. Hacker-Foegen MK, Janson M, Amagai M, Fairley JA, Lin MS (2003) Pathogenicity and epitope characteristics of antidesmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies. J Invest Dermatol 121:1373-1378
30. Herrero-Gonzalez JE, Mascaro JM, Herrero C, Dilling A, Zillikens D, Sitaru C (2006a) Autoantibodies from bullous systemic lupus erythematosus patients induce recruitment of leukocytes to the dermal-epidermal junction and subepidermal splits in cryosections of human skin. Arch Dermatol 142:1-3
31. Herrero-Gonzalez JE, Brauns O, Egner R, Ronspeck W, Mascaro JM Jr, Jonkman MF, Zillikens D, Sitaru C (2006b) Immunoadsorption against two distinct epitopes on human type XVII collagen abolishes dermal-epidermal separation induced in vitro by autoantibodies from pemphigoid gestationis patients. Eur J Immunol 36:1039-1048
32. 2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 119:1065-1073
33. Holland M, Hewins P, Goodall M, Adu D, Jefferis R, Savage CO (2004) Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin Exp Immunol 138:183-192
34. Hsu R, Lazarova Z, Yee C, Yancey KB (1997) Non-complement fixing, IgG4 autoantibodies predominate in patients with anti-epiligrin cicatricial pemphigoid. J Invest Dermatol 109:557-561
35. Janeway CA, Travers P, Walport M, Shlomchik M (2001) Immunobiology, 5th edn. Garland, New York, pp 360-361
36. Jones CC, Hamilton RG, Jordon RE (1988) Subclass distribution of human IgG autoantibodies in pemphigus. J Clin Immunol 8:43-49
37. Kelly SE, Cerio R, Bhogal BS, Black MM (1989) The distribution of IgG subclasses in pemphigoid gestationis: PG factor is an IgG1 autoantibody. J Invest Dermatol 92:695-698
38. Kim YH, Geoghegan WD, Jordon RE (1990) Pemphigus immunoglobulin G subclass autoantibodies: studies of reactivity with cultured human keratinocytes. J Lab Clin Med 115:324-331
39. Kottke MD, Delva E, Kowalczyk AP (2006) The desmosome: cell science lessons from human diseases. J Cell Sci 119:797-806
40. Kricheli D, David M, Frusic-Zlotkin M, Goldsmith D, Rabinov M, Sulkes J, Milner Y (2000) The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives (see comments). Br J Dermatol 143:337-342
41. Laffitte E, Skaria M, Jaunin F, Tamm K, Saurat JH, Favre B, Borradori L (2001) Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses. Br J Dermatol 144:760-768
42. Li N, Aoki V, Hans-Filho G, Rivitti EA, Diaz LA (2003) The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med 197:1501-1510
43. Liu Z (2002) Are anti-BP180 IgG1 or IgG4 autoantibodies pathogenic? J Invest Dermatol 119:989-990
44. Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJ (1993) A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 92:2480-2488
45. Mascaro JM Jr, Espana A, Liu Z, Ding X, Swartz SJ, Fairley JA, Diaz LA (1997) Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence. Clin Immunol Immunopathol 85:90-96
46. Mihai S, Chiriac MT, Herrero-Gonzales JE, Godall M, Jefferies AR, Savage CO, Zillikens D, Sitaru C (2007) Non-complement fixing IgG4 autoantibodies from patients with bullous pemphigoid activate leukocytes and induce dermal-epidermal separation. (submitted)
47. Mooney E, Gammon WR (1990) Heavy and light chain isotypes of immunoglobulin in epidermolysis bullosa acquisita. J Invest Dermatol 95:317-319
48. Morrison LH, Labib RS, Zone JJ, Diaz LA, Anhalt GJ (1988) Herpes gestationis autoantibodies recognize a 180-kDa human epidermal antigen. J Clin Invest 81:2023-2026
49. Ogawa MM, Hashimoto T, Nishikawa T, Castro RM (1989) IgG subclasses of intercellular antibodies in Brazilian pemphigus foliaceus - the relationship to complement fixing capability. Clin Exp Dermatol 14:29-31
50. Ohyama M, Amagai M, Tsunoda K, Ota T, Koyasu S, Hata J, Umezawa A, Nishikawa T (2002) Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris. J Invest Dermatol 118:199-204
51. Oostingh GJ, Sitaru C, Kromminga A, Lührs H, Zillikens D (2005) Subclass distribution of collagen type VII specific autoantibodies in patients with inflammatory bowel diseases. J Dermatol Sci 37:182-184
52. Parlowsky T, Welzel J, Amagai M, Zillikens D, Wygold T (2003) Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns. J Am Acad Dermatol 48:623-625
53. Patton T, Plunkett RW, Beutner EH, Deng JS, Jukic DM (2006) IgG4 as the predominant IgG subclass in pemphigoides gestationis. J Cutan Pathol 33:299-302
54. Payne AS, Hanakawa Y, Amagai M, Stanley JR (2004) Desmosomes and disease: pemphigus and bullous impetigo. Curr Opin Cell Biol 16:536-543
55. Payne AS, Ishii K, Kacir S, Lin C, Li H, Hanakawa Y, Tsunoda K, Amagai M, Stanley JR, Siegel DL (2005) Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 115:888-899
56. Ravetch JV, Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19:275-290
57. Rock B, Martins CR, Theofilopoulos AN, Balderas RS, Anhalt GJ, Labib RS, Futamura S, Rivitti EA, Diaz LA (1989) The pathogenic eVect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med 320:1463-1469
58. Schmidt E, Reimer S, Kruse N, Jainta S, Bröcker EB, Marinkovich MP, Giudice GJ, Zillikens D (2000) Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. J Invest Dermatol 115:842-848
59. Schur PH (1987) IgG subclasses - a review. Ann Allergy 58:89-96, 99
60. Shimanovich I, Mihai S, Oostingh GJ, Ilenchuk TT, Brocker EB, Opdenakker G, Zillikens D, Sitaru C (2004) Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 204:519-527
61. Shirakata Y, Shiraishi S, Sayama K, Miki Y (1990) Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus. J Dermatol 17:661-666
62. Sitaru C, Zillikens D (2005) Mechanisms of blister induction by autoantibodies. Exp Dermatol 14:861-875
63. Sitaru C, Kromminga A, Hashimoto T, Bröcker EB, Zillikens D (2002a) Autoantibodies to type VII collagen mediate Fc-gamma-dependent granulocyte activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol 161:301-311
64. Sitaru C, Schmidt E, Petermann S, Munteanu SL, Bröcker EB, Zillikens D (2002b) Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. J Invest Dermatol 118:664-671
65. Sitaru C, Powell J, Shimanovich I, Jainta S, Kirtschig G, Wojnarowska F, Zillikens D (2003) Pemphigoid gestationis: maternal sera recognise epitopes restricted to the N-terminal portion of the extracellular domain of BP180 not present on its shed ectodomain. Br J Dermatol 149:420-422
66. Sitaru C, Goebeler M, Zillikens D (2004) Bullöse Autoimmundermatosen (I): Pathogenese und Diagnostik. JDDG 2:123-139
67. Sitaru C, Mihai S, Otto C, Chiriac MT, Haußer I, Dotterweich B, Saito H, Rose C, Ishiko A, Zillikens D (2005) Induction of dermal-epidermal separation in mice by passive transfer of antibodies to type VII collagen. J Clin Invest 115:870-878
68. Sitaru C, Chiriac MT, Mihai S, Büning J, Gebert A, Ishiko A, Zillikens D (2006) Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol 177:3461-3468
69. Skaria M, Jaunin F, Hunziker T, Riou S, Schumann H, Bruckner-Tuderman L, Hertl M, Bernard P, Saurat JH, Favre B, Borradori L (2000) IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230. J Invest Dermatol 114:998-1004
70. Soundararajan S, Kikuchi Y, Joseph K, Kaplan AP (2005) Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol 115:815-821
71. Stanley JR, Amagai M (2006) Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 355:1800-1810
72. Suzuki M, Harada S, Yaoita H (1992) Purification of bullous pemphigoid IgG subclasses and their capability for complement fixation. Acta Derm Venereol 72:245-249
73. Suzuki M, Harada S, Owaribe K, Yaoita H (1996) Intracellular ionic changes induced by bullous pemphigoid IgG subclasses. Autoimmunity 23:181-197
74. 2+ induced by bullous pemphigoid IgG1 antibody. Autoimmunity 30:85-91
75. 2+ concentration in DJM-1 (human squamous cell carcinoma) cells. Autoimmunity 35:271-276
76. Tao MH, Smith RI, Morrison SL (1993) Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med 178:661-667
77. Terry WD, Fahey JL (1964) Subclasses of human gamma-2-globulin based on differences in the heavy polypeptide chains. Science 146:400-401
78. Warren SJ, Arteaga LA, Rivitti EA, Aoki V, Hans-Filho G, Qaqish BF, Lin MS, Giudice GJ, Diaz LA (2003) The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus. J Invest Dermatol 120:104-108
79. Wilson CL, Wojnarowska F, Dean D, Pasricha JS (1993) IgG subclasses in pemphigus in Indian and UK populations. Clin Exp Dermatol 18:226-230
80. van de Winkel JG, Capel PJ (1993) Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 14:215-221
81. Woodley DT, Ram R, Doostan A, Bandyopadhyay P, Huang Y, Remington J, Hou Y, Keene DR, Liu Z, Chen M (2006) Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol 126:1323-1330
82. Woof JM, Burton DR (2004) Human antibody-Fc receptor interactions illuminated by crystal structures. Nat Rev Immunol 4:89-99
83. Yamada H, Hashimoto T, Nishikawa T (1989) IgG subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation. J Invest Dermatol 92:585-587
84. Yamamoto K, Inoue N, Masuda R, Fujimori A, Saito T, Imajoh-Ohmi S, Shinkai H, Sakiyama H (2002) Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid. J Invest Dermatol 118:485-492
85. Yancey KB (2005) The pathophysiology of autoimmune blistering diseases. J Clin Invest 115:825-828
86. Yeh SW, Cavacini LA, Bhol KC, Lin MS, Kumar M, Duval M, Posner MR, Ahmed AR (2006) Pathogenic human monoclonal antibody against desmoglein 3. Clin Immunol 120:68-75
87. Zillikens D (1999) Acquired skin disease of hemidesmosomes. J Dermatol Sci 20:134-154
88. Zillikens D, Rose PA, Balding SD, Liu Z, Olague-Marchan M, Diaz LA, Giudice GJ (1997) Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 109:573-579